Background: The prevalence of symptoms suggesting distal symmetric polyneuropathy (DSP) was reported to be higher among deployed veterans (DV) to the Persian Gulf in 1990 -1991 than to control non-deployed veterans (NDV). The authors therefore compared the prevalence of DSP by direct examination of DV and their spouses to control NDV and spouses. Methods: The authors performed standardized neurologic examinations on 1,061 DV and 1,128 NDV selected from a cohort of veterans who previously participated in a national mail and telephone survey. Presence of DSP was evaluated by history, physical examination, and standardized electrophysiologic assessment of motor and sensory nerves. Similar examinations were performed without electrophysiologic tests in 484 DV spouses and 533 NDV spouses. Statistical analyses were performed with appropriate adjustments for the stratified sampling scheme. Results: No differences between adjusted population prevalence of DSP in DV and NDV were found by electrophysiology (3.7% vs 6.3%, p ϭ 0.07), by neurologic examination (3.1% vs 2.6%, p ϭ 0.60), or by the methods combined (6.3% vs 7.3%, p ϭ 0.47). Excluding veterans with non-military service related diseases that may cause DSP did not alter outcomes. DV potentially exposed to neurotoxins from the Khamisiyah ammunition depot explosion did not significantly differ in DSP prevalence compared to non-exposed DV. The prevalence of DSP in DV spouses did not differ from NDV spouses (2.7% vs 3.2%, p ϭ 0.64). Conclusions: Neither veterans deployed during the Gulf War era nor their spouses had a higher prevalence of DSP compared to NDV and spouses.
NEUROLOGY 2004;63: 1070 -1077 In August 1990 the United States first deployed troops to the Persian Gulf area in Operation Desert Shield. By the end of the armed conflict (Operation Desert Storm), almost 700,000 US military personnel had been deployed to the theater of operations. Although less than 200 battle deaths occurred, troops reported possible exposure to a variety of potentially harmful environmental agents including medical prophylaxis (anthrax and botulinum toxoid vaccinations and cholinesterase inhibitors), pesticides, oil well fire smoke, chemical agents, infectious agents, and psychological trauma and stressors. 1 In addition, the Department of Defense determined that a subgroup of veterans may have been exposed to low levels of organophosphate nerve agents following the explosion at the Khamisiyah, Iraq, ammunition depot. 2, 3 Shortly after returning home, a variety of neuro-logic symptoms that included excessive fatigue, myalgia, cognitive dysfunction, numbness, dysesthesias, paresthesias, muscle cramps, or weakness in feet and hands [4] [5] [6] [7] were reported among some American, [8] [9] [10] [11] British, 12, 13 and Canadian 14 veterans. In response, the Department of Veterans Affairs initiated a retrospective, population-based, mail (Phase I) and telephone (Phase II) cohort survey, "National Health Survey of Gulf War Era Veterans and Their Families." This survey compared the health of 15,000 troops deployed to the Persian Gulf region from August 1990 to July 1991 to a similar number of veterans in military service during the same time period but who were not deployed to the Persian Gulf region. 15 The survey found that DV reported (p Ͻ 0.05) higher prevalences than NDV of several neurologic complaints, including neuralgia (4.0% vs 2.1%), muscle disorders (7.0% vs 4.0%), recurrent headaches (32.6% vs 14.9%), poor concentration (35% vs 13%), fatigue (38% vs 15%), and numbness or tingling of limbs (33% vs 21%).
Previous small studies employing neurologic examinations and electrophysiologic tests reported Gulf War DV differed 16, 17 or did not differ 18, 19 from various controls. The largest controlled study used quantitative sensory and autonomic function studies and found objective neurophysiologic abnormalities were not more frequent in UK Gulf War DV than in three other groups. 18 In addition, self-reported symptoms of numbness or dysesthesias do not accurately diagnose distal symmetric polyneuropathy (DSP) by comparison to neurologic examination or electrophysiologic nerve conduction studies. 20, 21 Therefore, the present (Phase III) study was initiated objectively to evaluate peripheral nerve function among DV and NDV and their spouses. Details of the methods employed and results of the overall study are reported separately. 22 This report evaluates whether DV and spouses had a higher prevalence of objective DSP than NDV and spouses. Spouses were included to evaluate concerns that returning DV might have brought home something, such as an infectious agent or environmental contaminant, which could adversely affect spouses. We also analyzed a subgroup of deployed veterans who were determined by the Department of Defense to have been at risk of exposure to low levels of organophosphate nerve agents resulting from demolition of the ammunition depot at Khamisiyah. 3
Methods.
The sample for the present study was derived from a sample of 15,000 deployed and 15,000 non-deployed servicemen selected to participate in an earlier study performed in 1995-1996. 15 Briefly, for the earlier study, the Department of Defense's Defense Manpower Data Center (DMDC) provided military and demographic information for the 693,826 American troops who were deployed in the Persian Gulf area during the Gulf War, and 800,680 troops who were in the military between September 1990 and May 1991 but did not serve in the Persian Gulf theater (approximately one-half of all non-deployed troops). The sample was stratified and oversampled by sex and unit component (active duty, National Guard, reservists) to ensure that these subgroups were adequately represented. (Published research suggested that women and non-active duty servicemen might be more vulnerable to deployment related illnesses than active-duty servicemen.) Therefore, one-fifth of the final sample was women (3,000), approximately one-quarter were National Guard (4,000), and onethird were reservists (5,000). The proportion of these subgroups in the population of all deployed troops were 7% women, 7% National Guard, and 10% reservists. A similarly stratified random sampling approach was adopted to select the non-deployed sample.
The 4,879 individuals (1,996 deployed, 2,883 non-deployed) selected to participate in the present study were derived from participants in the earlier study, further stratified by last known phone number to select individuals likely to live closer to one of the research examination centers. A total of 53.2% of deployed (1,061) and 39.1% of non-deployed (1,128) eligible individuals were examined. Analysis of participation bias 22 demonstrated that while participants and non-participants differed in several characteristics, non-participation bias between DV and NDV was qualitatively and quantitatively similar.
A survey research organization contacted and invited veterans by mail to participate with their spouse in the study. Those who agreed to participate were provided travel, hotel, per diem costs, and an honorarium of $200. All subjects signed an informed consent, which had been approved by the Veterans Administration's Hines Cooperative Studies Program Human Rights Committee and the Institutional Review Boards at each of the 16 nationally distributed participating VA Medical Centers. 22 A standardized, comprehensive medical and neuropsychological examination was performed between 1999 and 2001. The aver-age examination time was 12 hours and took 1 to 2 days. Board certified/eligible neurologists conducted the neurologic examinations and trained electromyographers performed the electrophysiologic examinations. With few exceptions, neither the examining neurologists nor electromyographers were aware of the deployment status of participants since they did not participate in other aspects of the Phase III examination. A standardized medical and neuropsychologic history and a physical examination were performed. The standardized neurologic examination included a clinical evaluation of peripheral nerves of feet and legs. The sensory examination included testing of pain, light touch, vibration, and position sense. Responses were determined bilaterally at the first and fifth toes, ankle, and medial malleous and were recorded as normal, decreased, absent, or not applicable due to missing limb. Vibratory sense was measured using a 128 Hz tuning fork. Pain sensation was determined using a disposable safety pin. Light touch was measured with a piece of cotton. The results of muscle stretch reflexes (at ankle, knee, biceps, and triceps) and the Babinski response were recorded. The motor examination included inspection of muscles (toe flexors and extensors, foot everters and invertors, ankle plantar flexors and dorsiflexors, knee flexors and extensors, and hip abductors, adductors, and flexors) for bulk and tone and graded for strength using the Medical Research Council muscle testing system. 23 Gait was assessed for presence of hemiparesis, spasticity, parkinsonism, foot drop, or other conditions. Lower extremity coordination was evaluated for gait ataxia, heel to shin testing, and rapid foot tap.
A blood sample was drawn from each veteran and included assays for thyroid stimulating hormone, fasting glucose, and creatinine. In addition, veterans, but not spouses, underwent a standardized electrophysiologic examination. One median, peroneal, and tibial motor nerve and one radial and sural sensory nerve were studied. Electrode placement and distances from distal stimulation were specified. Limb temperature was maintained at Ն32°C
. Data collected for motor nerves included distal and proximal latencies, distal and proximal amplitudes, conduction velocities, and minimum F-wave latencies. For the superficial radial and sural nerves, data included onset and peak sensory nerve action potentials (SNAP) latencies, SNAP amplitude, and conduction velocity. One electromyographer (B.P.) reviewed all electrophysiologic data and most waveforms to verify accuracy of data entry and identify study sites with possible technical problems.
The diagnosis of DSP was defined as a distal sensory, motor, or sensorimotor polyneuropathy that was identified on the basis of abnormalities on neurologic examination, nerve conduction study, or both (see tables E-1 and E-2, on the Neurology Web site at www.neurology.org). We were concerned that some chronic diseases present in both deployed and non-deployed veterans might obscure a smaller group of peripheral nerve abnormalities associated with deployment. Therefore, we analyzed the groups both before and after excluding the following selected diseases that commonly affect peripheral nerves: history of alcohol dependence (Diagnostic and Statistical Manual of Mental Disorders, 4th ed. 24 ), HIV infection or AIDS (participant self report), hypothyroidism (taking thyroid medication or thyroid stimulating hormone level of Ͼ10 IU/mL), diabetes mellitus (taking hypoglycemic medications or a fasting blood sugar of Ͼ125 mg/dL), renal insufficiency (serum creatinine Ͼ2.4 mg/dL), and past or current treatment with a potential neurotoxic medication (antineoplastic drugs, anti-HIV drugs, amiodarone, phenytoin, dapsone, ethambutol, ethionamide, gold salts, hydralazine, isoniazid without pyridoxine, nitrofurantoin, or thalidomide). Data from participants with the following diseases, based on self-report and physical examination, were also excluded: systemic lupus erythematosus, Sjögren syndrome, scleroderma, and malabsorption syndrome. Participants with both upper and lower motor neuron neurologic signs were also excluded since these signs implied CNS disease.
Self-reported symptoms suggestive of DSP were compared with the DSP diagnosis based on objective data from the neurologic examination and electrophysiology studies on the same participants. Self-reported data came from the Phase I and II research study performed in 1995, and the current, Phase III study, in which participants were asked about the presence of peripheral neuropathy symptoms or a medical diagnosis in the preceding 12 months.
Sample size estimation was based on the expected prevalence of medical and psychiatric conditions among veterans. The study size of approximately 1,000 deployed and 1,000 non-deployed veterans had 80% statistical power to detect prevalence differences of 1.5% for peripheral neuropathy (assumed prevalences among DV ϭ 1.7%, NDV ϭ 0.2%), and among spouses' prevalence differences of 2.0% for PN (assuming a base rate of 2.1%). In tables 1 and E-3 (available on the Neurology Web site at www.neurology-.org), rates were obtained using Statistical Analysis Software (SAS Version 8). 25 We used Fisher's exact test and t-tests for categorical and continuous outcomes, and for comparisons of sociodemographic and military status. In this study a stratified random sample was obtained with oversampling of female veterans, National Guard, and Reserve members. As an adjustment for oversampling, calculation of sampling weights was based on deployment status, sex, and duty type. Because of the complexity of this sampling scheme, we used SUDAAN software to analyze the veteran data. 26 Population prevalences and odds ratios with p values and corresponding 99.3% and 95% CI were calculated for the primary outcome, peripheral neuropathy, and secondary outcomes. The 99.3% confidence level was derived using Bonferroni adjustment to obtain a 0.05 level of confidence for the group of seven primary outcomes, which includes peripheral neuropathy. Spouse data were analyzed in SAS.
Results.
A total of 1,061 DVs and 1,128 NDVs were examined. DVs were nearly 2 years younger, less well educated, had a slightly lower annual income, were more likely to be African American, and were more likely to be single than NDV (see table 1 ). These differences were similar to true differences in these two populations. To assess non-participation bias, we compared Phase I/II data from participants and non-participants on a variety of selfreported medical symptoms. While veterans who reported more symptoms in Phases I/II were more likely to participate in Phase III, the level of participation bias between DV and NDV was similar. 22 Approximately 65% of the spouses of participating DVs and 63% of the spouses of participating NDVs were examined. The spouses of the DVs were about 2 years younger and were better educated than the spouses of NDVs (see table E-3 online at www.neurology.org). Table 2 lists the prevalence of non-military service related diseases or conditions among DV and NDV that have been associated with DSP. Twenty-three DV, 21 NDV, 1 spouse of DV, and 7 spouses of NDV had a diagnosis of peripheral neuropathy and had non-military medical conditions that could have caused the neuropathy. These individuals were removed from analyses when co-existing conditions were excluded. Thus, after medical exclusions, we analyzed 130 veteran participants and 22 spouses of veterans with DSP. No differences were noted in the nonexcluded and excluded groups, except that collagen vascular diseases were more prevalent in the NDV cohort (prevalence ϭ 0.03% in DV, 0.3% in NDV, p ϭ 0.04). No differences were found between spouse cohorts. Table 3 summarizes the adjusted population prevalence of self-reported symptoms suggestive of peripheral neuropathy during the Phase I/II (in 1995), and the Phase III examination, and the objective prevalence of DSP diagnosed by neurologic examination, nerve conduction examination, or either. Figures are given for all veterans in both groups and for those veterans who were not excluded for non-military service related medical conditions that could cause peripheral neuropathy. Compared to NDVs, DVs self-reported more limb numbness or tingling occurring in 1995 and having developed after July 1, 1991, and still present in 1995. However, they did not report a higher prevalence of physician diagnosed peripheral neuropathy at the time of the Phase III examination. A diagnosis of DSP was made by neurologic examination or nerve conduction study in 4.7% of DVs with non-military service related co-existing medical conditions excluded vs 5.8% of NDVs with co-medical conditions excluded. No differences were found between the DVs and NDVs in prevalence of a DSP diagnosed by neurologic examination, nerve conduction studies, or either. Similarly, between DV and NDV, there was no statistical association between self-reported limb numbness or tingling (DV: p ϭ 0.49, NDV: p ϭ 0.44) or self-reported peripheral neuropathy at the time of the research examination (DV: p ϭ 0.13, NDV: p ϭ 0.83) and the objective finding of DSP by neurologic examination and/or electrophysiology. Table 4 summarizes the adjusted population prevalence of those Phase III DVs who may or may not have been exposed to the neurotoxins of the Khamisiyah ammunition dump explosion with respect to self-reported symptoms suggestive of peripheral neuropathy in 1995, the preva- lence of self-reported symptoms suggestive of or the diagnosis of peripheral neuropathy in the Phase III examination, and the objective prevalence of DSP diagnosed by neurologic examination, nerve conduction examination, or either. Khamisiyah exposed DVs compared to DVs who were not exposed self-reported more limb numbness or tingling in 1995, but reported no differences in symptoms of peripheral neuropathy at the time of the Phase III examination, and a substantially lower prevalence of physician diagnosed peripheral neuropathy (0.6% among Khamisiyah exposed, 3.2% among Khamisiyah nonexposed, p ϭ 0.01). No differences were found between the two groups in prevalence of a DSP diagnosed by neurologic examination, nerve conduction studies, or both. Table 5 summarizes the adjusted population prevalence of self-reported symptoms suggestive of peripheral neuropathy and the diagnosis of DSP based solely on a neurologic examination between spouses of DVs and NDVs. No differences between the two groups were found. Table 6 lists the types of peripheral neuropathy (sen-sory, motor, or sensory-motor) diagnosed in DV and NDV and their spouses. No significant differences in the types of neuropathy were identified.
Discussion. This study is the largest controlled, objective evaluation of the neurologic health of Gulf War DV and NDV and their spouses. Prior research has consistently reported a higher prevalence of selfreported symptoms of peripheral neuropathy in Gulf War DV by comparison to NDV. However, the validity of these results is suspect since self-reported symptoms have poor diagnostic accuracy in predicting the presence of a DSP as determined by neurologic examination or electrophysiologic nerve conduction study. 20, 21 One prior study electrophysiologically evaluated small fiber function in peripheral nerves in Gulf War-ill vs Gulf War-well veterans and failed to find an increase in abnormalities in muscles, neuromuscular junctions, or peripheral nerves. 18 The present study included an extensive medical history, medical examination, neurologic examination, blood laboratory assays, and electrophysiologic evaluations. No differences were found in the prevalence of DSP in DV compared to NDV. Likewise, no differences in prevalence of DSP diagnosed by physical examination were found between the spouses of DV and NDV. The absence of statistical differences remained after excluding medical conditions that commonly cause peripheral neuropathy (such as diabetes mellitus). Thus, there is no evidence that deployment to the Persian Gulf caused chronic peripheral nerve damage that is present 10 years later. Furthermore, potential exposure to neurotoxic chemicals released following the Khamisiyah ammunition dump explosion is not associated with chronic DSP 10 years later.
This study does not address whether acute or subacute transient peripheral nerve dysfunction may have occurred in some DV as a result of Gulf War service that resolved between exposure and the research examination. However, evidence against a transient neurologic symptom hypothesis was the finding that a study of hospital records of 547,000 Gulf War veterans who had remained on active duty in the 2 years following the war found no consistent pattern for excess nervous system diseases. 27 In addition, a study of mortality rates of US Persian Gulf War DV found no increase in mortality from medical diseases including neurologic diagnoses compared to NDV and the rate was lower than the age-matched general population. 28 Other limitations of the present study include potential participation bias since only 53% of DV and 39% of NDV invited to participate were examined. The reasons for non-participation were numerous and included refusal of the contacted veteran to participate, inability to locate the veteran, and prior death. A possible selection bias may have occurred if DV with neurologic complaints were more willing to participate than NDV with neurologic complaints. Although we cannot exclude this possibility, the observation that the DV and spouses had a lower prevalence of peripheral neuropathy than did NDV and their spouses suggests that significant ascertainment bias did not occur. If a selection bias occurred for both DV and NDV, the overall prevalence of DSP between both groups would be increased but the absence of a statistical difference between NDV and DV likely would still be present.
Finally, it is possible that we missed some cases of small fiber peripheral neuropathy due to the limitations of the neurologic examinations and because nerve conduction studies preferentially test large myelinated fibers. 29 However, our neurologic examination partially evaluated small fibers by testing pain in the toes. That we identified additional cases of neuropathy by the neurologic examinations, which were not also found on the electrophysiologic tests, suggests that we may have been successful in identi-fying both small and large fiber neuropathies. This study did not evaluate autonomic nervous system function either in its questionnaire or objective tests. Therefore, patients with autonomic neuropathy without concomitant DSP would not have been identified. However, a UK study that employed autonomic nervous system testing did not find DV had more objective autonomic nervous system abnormalities than controls. 18 Nerve conduction studies correlate well with clinical signs and nerve histology of DSP resulting from a wide variety of toxic agents such as heavy metals and solvents. [30] [31] [32] In the present study, a similar association was found and veterans who had abnormal peripheral nerve conduction studies were 3.89 times more likely to have DSP found on neurologic physical examination (1.41 to 10.74, p ϭ 0.009).
There is little information regarding the prevalence of DSP in young adults in the general population. A group of 286 neighbors living in Newark, NJ, and Verona, MO, with a mean age of 56 years and without a history of diabetes mellitus, alcoholism, or exposure to neurotoxins were studied as a normal reference group. 29 Limb numbness was self-reported by 6.8%, tingling by 8.3%, and burning by 3.6%, while Ͼ15% were found to have abnormally slow sural nerve conduction velocities when our cut-off value of Ͻ40 m/second was used.
A study of 1,972 non-Vietnam veterans between 30 and 48 years performed by the Centers for Disease Control and Prevention reported abnormal vibratory thresholds of the great toe in 4.7%, abnormal sural nerve conduction velocities in 7.5%, and abnormally low sural sensory amplitudes in 7.6%. 33 These numbers are similar to those found in this study.
